Cargando…

Change in R wave in lead V1 predicts survival of patients with pulmonary arterial hypertension

Clinical guidelines for pulmonary hypertension recommend evaluating treatment response through various methods; however, electrocardiography (ECG) is not included as one of the methods of choice. We aimed to identify ECG parameters that correlated with prognosis in patients with pulmonary arterial h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Shinji, Ogawa, Aiko, Matsubara, Hiromi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952289/ https://www.ncbi.nlm.nih.gov/pubmed/29693480 http://dx.doi.org/10.1177/2045894018776496

Ejemplares similares

Response to exercise in patients with pulmonary arterial hypertension treated with combination therapy
por: Nishizaki, Mari, et al.
Publicado: (2021)

High Right Ventricular Afterload during Exercise in Patients with Pulmonary Arterial Hypertension
por: Nishizaki, Mari, et al.
Publicado: (2021)

Balloon Pulmonary Angioplasty: A Treatment Option for Inoperable Patients with Chronic Thromboembolic Pulmonary Hypertension
por: Ogawa, Aiko, et al.
Publicado: (2015)

Epoprostenol sodium for treatment of pulmonary arterial hypertension
por: Saito, Yukihiro, et al.
Publicado: (2015)

Treatment of Vascular Injury During Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension
por: Ejiri, Kentaro, et al.
Publicado: (2022)

A burden of rare variants in BMPR2 and KCNK3 contributes to a risk of familial pulmonary arterial hypertension
por: Higasa, Koichiro, et al.
Publicado: (2017)

3D in vitro Model of Vascular Medial Thickening in Pulmonary Arterial Hypertension
por: Morii, Chiharu, et al.
Publicado: (2020)

Investigation of safety and efficacy of the new more thermostable formulation of Flolan (epoprostenol) in Japanese patients with pulmonary arterial hypertension (PAH)—An open-label, single-arm study
por: Mihara, Kazuko, et al.
Publicado: (2018)

Antiproliferative effect of selexipag active metabolite MRE‐269 on pulmonary arterial smooth muscle cells from patients with chronic thromboembolic pulmonary hypertension
por: Kuramoto, Kazuya, et al.
Publicado: (2023)

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension concomitant with Klippel–Trenaunay–Weber syndrome
por: Suetomi, Takeshi, et al.
Publicado: (2022)

Improvements in French risk stratification score were correlated with reductions in mean pulmonary artery pressure in pulmonary arterial hypertension: a subanalysis of the Japan Pulmonary Hypertension Registry (JAPHR)
por: Tamura, Yuichi, et al.
Publicado: (2021)

Thrombin‐mediated activation of Akt signaling contributes to pulmonary vascular remodeling in pulmonary hypertension
por: Ogawa, Aiko, et al.
Publicado: (2013)

Importance of differential diagnosis of pulmonary hypertension
por: Ogawa, Aiko
Publicado: (2013)

Noninvasive pulmonary artery wave intensity analysis in pulmonary hypertension
por: Quail, Michael A., et al.
Publicado: (2015)

Chronic Thromboembolic Pulmonary Hypertension: Endovascular Treatment
por: Ahn, Chul-Min, et al.
Publicado: (2019)

Leptin levels predict survival in pulmonary arterial hypertension
por: Tonelli, Adriano R., et al.
Publicado: (2012)

Nanoparticle-Mediated Drug Delivery System for Pulmonary Arterial Hypertension
por: Nakamura, Kazufumi, et al.
Publicado: (2017)

The impact of pulmonary arterial hypertension-targeted therapy on survival in Chinese patients with idiopathic pulmonary arterial hypertension
por: Zeng, Wei-Jie, et al.
Publicado: (2012)

Wave Intensity Analysis Provides Novel Insights Into Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
por: Su, Junjing, et al.
Publicado: (2017)

Current Treatment Strategies and Nanoparticle-Mediated Drug Delivery Systems for Pulmonary Arterial Hypertension
por: Nakamura, Kazufumi, et al.
Publicado: (2019)

Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertension
por: Condliffe, Robin, et al.
Publicado: (2012)

Predictive value of chest HRCT for survival in idiopathic pulmonary arterial hypertension
por: Kacprzak, Aneta, et al.
Publicado: (2021)

Non-invasive Assessment of Pulmonary Artery Wave Reflection in Dogs With Suspected Pulmonary Hypertension
por: Yoshida, Tomohiko, et al.
Publicado: (2021)

Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary arterial hypertension
por: Kuwana, Masataka, et al.
Publicado: (2023)

Long COVID syndrome after SARS‐CoV‐2 survival in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Wieteska‐Miłek, Maria, et al.
Publicado: (2023)

Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension
por: Lang, Irene, et al.
Publicado: (2017)

Retinal vessel changes in pulmonary arterial hypertension
por: DuPont, Mariana, et al.
Publicado: (2022)

Pulmonary artery blood flow dynamics in chronic thromboembolic pulmonary hypertension
por: Tsubata, Hideo, et al.
Publicado: (2023)

Plasma exosomal miR-596: a novel biomarker predicts survival in patients with idiopathic pulmonary artery hypertension
por: Huang, Yang, et al.
Publicado: (2021)

Kynurenine metabolites predict survival in pulmonary arterial hypertension: A role for IL-6/IL-6Rα
por: Cai, Zongye, et al.
Publicado: (2022)

Changes in Large Pulmonary Arterial Viscoelasticity in Chronic Pulmonary Hypertension
por: Wang, Zhijie, et al.
Publicado: (2013)

Exercise-Induced Changes in Pulmonary Artery Stiffness in Pulmonary Hypertension
por: Forouzan, Omid, et al.
Publicado: (2019)

Intratracheal Administration of Prostacyclin Analogue–incorporated Nanoparticles Ameliorates the Development of Monocrotaline and Sugen-Hypoxia-induced Pulmonary Arterial Hypertension
por: Akagi, Satoshi, et al.
Publicado: (2016)

The effect of docosahexaenoic acid on predicting the survival of patients with idiopathic pulmonary arterial hypertension
por: Huai, Xu, et al.
Publicado: (2021)

Multicentre randomised controlled trial of balloon pulmonary angioplasty and riociguat in patients with chronic thromboembolic pulmonary hypertension: protocol for the MR BPA study
por: Kawakami, Takashi, et al.
Publicado: (2020)

Pulmonary artery dysfunction in chronic thromboembolic pulmonary hypertension
por: Chibana, Hidetoshi, et al.
Publicado: (2017)

Contemporary survival of patients with pulmonary arterial hypertension and congenital systemic to pulmonary shunts
por: Vijarnsorn, Chodchanok, et al.
Publicado: (2018)

Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension
por: Kopeć, Grzegorz, et al.
Publicado: (2017)

The evolution of survival of pulmonary arterial hypertension over 15 years
por: Hendriks, Paul M., et al.
Publicado: (2022)

Changes in the Characteristics and Initial Treatments of Pulmonary Hypertension Between 2008 and 2020 in Japan
por: Tamura, Yuichi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_afvs96218gpmjirv7hnm067j6e